| Line item | 2026 ANNUAL | 2025 ANNUAL |
|---|---|---|
| Total Liabilities | $145.85M | $228.05M |
| -Long Term Capital Lease Obligation | $51.02M | $58.42M |
| Derivative Product Liabilities | $5.45M | $0.00 |
| Convertible preferred securities | $2.01M | $0.00 |
| Total Equity | $180.03M | $76.15M |
| Stockholders' Equity | $180.03M | $76.15M |
| Capital Stock | $145,000.00 | $138,000.00 |
| -Common Stock | $145,000.00 | $138,000.00 |
| Additional Paid-In Capital | $379.34M | $225.16M |
| Retained Earnings | -$199.46M | -$149.14M |
| -Long Term Debt | $474,000.00 | $12.00M |
| Long Term Debt and Capital Lease Obligation | $51.49M | $70.42M |
| Total Non-Current Liabilities | $58.96M | $70.42M |
| Total Current Liabilities | $86.89M | $157.63M |
| Payables | $9.05M | $3.96M |
| -Accounts Payable | $9.05M | $3.96M |
| Current Accrued Expenses | $3.74M | $572,000.00 |
| Short-Term Debt and Capital Lease Obligation | $69.07M | $149.50M |
| -Current Debt | $3.37M | – |
| -Current Capital Lease Obligation | $65.70M | $149.50M |
| Current Deferred Liabilities | $0.00 | $3.59M |
| Other Current Liabilities | $5.03M | – |
| Other Non-Current Assets | $520,000.00 | – |
| Total Assets | $325.87M | $304.20M |
| Total Current Assets | $44.25M | $6.41M |
| Cash and Cash Equivalents & Short-Term Investments | $9.66M | $2.40M |
| -Cash and Cash Equivalents | $9.66M | $2.40M |
| Receivables | $12.54M | $3.79M |
| -Accounts Receivable | $12.54M | $3.79M |
| Other Current Assets | $2.20M | $223,000.00 |
| Total Non-Current Assets | $281.63M | $297.79M |
| Net PPE | $226.59M | $297.79M |
| -Gross PPE | $235.00M | $300.47M |
| -Accumulated Depreciation | -$8.40M | -$2.68M |
| Goodwill and Other Intangible Assets | $54.51M | $0.00 |
| -Goodwill | $54.51M | $0.00 |
| Line item | 2026 ANNUAL | 2025 ANNUAL |
|---|---|---|
| Free Cash Flow | $12.19M | -$8.60M |
| Operating Cash Flow | $39.07M | -$7.22M |
| Net cash flow from continuing operations | $39.07M | -$7.22M |
| Net Business Purchase and Sale | $1.71M | $0.00 |
| Financing Cash Flow | -$6.63M | $11.00M |
| Net Cash Flow from Continuing Financing Activities | -$6.63M | $11.00M |
| Net Issuance Payments Of Debt | -$89.52M | -$102.74M |
| Net Common Stock Issuance | $15.00M | $0.00 |
| Proceeds from Stock Option Exercised | $4.45M | $0.00 |
| Net Other Financing Charges | $63.44M | $113.74M |
| Ending Cash Balance | $9.66M | $2.40M |
| Net Change in Cash | $7.27M | $2.40M |
| Net PPE Purchase and Sale | -$26.88M | -$1.38M |
| Net Cash Flow from Continuing Investing Activities | -$25.17M | -$1.38M |
| Net cash flow from investing | -$25.17M | -$1.38M |
| Net Income from Continuing Operations | -$50.32M | -$72.73M |
| Gain/Loss from Continuing Operations | $2.81M | -$414,000.00 |
| Depreciation & Depletion & Amortization | $60.34M | $80.66M |
| Other Non-Cash Items | $21.03M | $30.92M |
| Change in Working Capital | $3.91M | -$44.19M |
| -Change in Receivables | -$8.54M | -$3.79M |
| -Change in Prepaid Assets | -$1.87M | $111,000.00 |
| -Change in Payables and Accrued Expense | $4.11M | -$10.02M |
| -Change In Other Working Capital | $10.73M | -$31.08M |
| Beginning Cash Balance | $2.40M | $0.00 |
| -Change in Other Current Assets | -$520,000.00 | $581,000.00 |
No comments yet — be the first to weigh in on CHRN.